These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
492 related items for PubMed ID: 11320344
1. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. Hutchins SS, Redd SC, Schrag S, Kruszon-Moran D, Wooten K, McQuillan GM, Bellini W, Meyer PA, Hadler S. MedGenMed; 2001 Jan 24; ():E5. PubMed ID: 11320344 [Abstract] [Full Text] [Related]
2. Population immunity to measles in the United States, 1999. Hutchins SS, Bellini WJ, Coronado V, Jiles R, Wooten K, Deladisma A. J Infect Dis; 2004 May 01; 189 Suppl 1():S91-7. PubMed ID: 15106096 [Abstract] [Full Text] [Related]
3. Seroprevalence of measles antibody in the US population, 1999-2004. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. J Infect Dis; 2007 Nov 15; 196(10):1459-64. PubMed ID: 18008224 [Abstract] [Full Text] [Related]
4. Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team. Markowitz LE, Albrecht P, Rhodes P, Demonteverde R, Swint E, Maes EF, Powell C, Patriarca PA. Pediatrics; 1996 Jan 15; 97(1):53-8. PubMed ID: 8545224 [Abstract] [Full Text] [Related]
5. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe. Obi CL, Tswana SA, Moyo SR, Berejena C. Cent Afr J Med; 1996 May 15; 42(5):135-8. PubMed ID: 8771931 [Abstract] [Full Text] [Related]
6. A population-based serologic survey of immunity to tetanus in the United States. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. N Engl J Med; 1995 Mar 23; 332(12):761-6. PubMed ID: 7862178 [Abstract] [Full Text] [Related]
7. Humoral and cellular immune response after measles vaccination in Taiwan. Huang CL, Yang YH, Wang LC, Lin YT, Tsai YY, Chiang BL. J Microbiol Immunol Infect; 2005 Jun 23; 38(3):169-75. PubMed ID: 15986066 [Abstract] [Full Text] [Related]
8. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan. Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM. J Med Virol; 1997 Jan 23; 51(1):32-5. PubMed ID: 8986946 [Abstract] [Full Text] [Related]
9. Rubella seropositivity in the United States, 1988-1994. Dykewicz CA, Kruszon-Moran D, McQuillan GM, Williams WW, Van Loon FP, Cossen C, Forghani B, Hadler SC. Clin Infect Dis; 2001 Oct 15; 33(8):1279-86. PubMed ID: 11565065 [Abstract] [Full Text] [Related]
10. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign. Kelly HA, Gidding HF, Karapanagiotidis T, Leydon JA, Riddell MA. BMC Public Health; 2007 Jun 08; 7():99. PubMed ID: 17555601 [Abstract] [Full Text] [Related]
19. Predicting and comparing long-term measles antibody profiles of different immunization policies. Lee MS, Nokes DJ. Bull World Health Organ; 2001 Nov 01; 79(7):615-24. PubMed ID: 11477964 [Abstract] [Full Text] [Related]
20. [Presence of IgG class antibodies anti-measles virus in sera of subjects in different age]. Cześcik A, Dunal M, Trzcińska A, Siennicka J. Med Dosw Mikrobiol; 2012 Nov 01; 64(1):73-8. PubMed ID: 22808732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]